0001579600-22-000001.txt : 20220906
0001579600-22-000001.hdr.sgml : 20220906
20220906113159
ACCESSION NUMBER: 0001579600-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220906
DATE AS OF CHANGE: 20220906
EFFECTIVENESS DATE: 20220906
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: T3D Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579600
IRS NUMBER: 461674269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-457972
FILM NUMBER: 221227437
BUSINESS ADDRESS:
STREET 1: 1100 BEARGLADES LANE
CITY: RALEIGH
STATE: NC
ZIP: 27615
BUSINESS PHONE: 919-949-0517
MAIL ADDRESS:
STREET 1: 1100 BEARGLADES LANE
CITY: RALEIGH
STATE: NC
ZIP: 27615
D
1
primary_doc.xml
X0708
D
LIVE
0001579600
T3D Therapeutics, Inc.
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
919-949-0517
DELAWARE
None
None
Corporation
true
John
Didsbury
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Promoter
Charles
Lineberry
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Barry
Buzogany
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
John
Golden
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Tom
Mendell
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
David
Keim
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Donald
Parker
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-08-26
false
true
false
0
7500000
6002712
1497288
false
23
0
0
0
Proceeds will be used for working capital which may include normal compensation to executive officers.
false
T3D Therapeutics, Inc.
John Didsbury
John Didsbury
President and Chief Executive Officer
2022-09-03